Axel Bex

8PUBLICATIONS
45CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Implementation science and evaluationPredictive and prognostic markersSocial program evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 11, 2026
Modern management of locally advanced renal cancers with inferior vena cava thrombus.

|Sep 20, 2024
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial.

Robert J Motzer, Axel Bex, Paul Russo

|Jul 22, 2022
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis.

Caroline S Clarke, Mariya Melnychuk, Angus I G Ramsay

|May 03, 2022
Surgical margins after partial nephrectomy as prognostic factor for the risk of local recurrence in pT1 RCC: a systematic review and narrative synthesis.

Michaël M E L Henderickx, Suraj V Baldew, Lorenzo Marconi

|Apr 26, 2022
Loss associated with subtractive health service change: The case of specialist cancer centralization in England.

Georgia B Black, Victoria J Wood, Angus I G Ramsay

|Feb 25, 2022
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer.

Bhavna Oza, Tim Eisen, Eleni Frangou

Pageof 2

Frequent Collaborators

2 joint publications

Bhavna Oza

2 joint publications

Tim Eisen

2 joint publications

Caroline S Clarke

2 joint publications

Grant D Stewart